Michael W. Triplett - 12 Aug 2024 Form 4 Insider Report for Cigna Group (CI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Aug 2024, 16:30:13 UTC
Prior SEC filing
05 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Matthew Arnold, attorney-in-fact

Key filing fact

Michael W. Triplett filed Form 4 for Cigna Group (CI) on 14 Aug 2024.

Key facts

  • This page summarizes Michael W. Triplett's Form 4 filing for Cigna Group (CI).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Aug 2024, 16:30.

Change

  • Previous filing in this sequence was filed on 05 Mar 2024.
  • Current net transaction value: -$1,176,079.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI transaction

Common Stock, $.01 Par Value

Options Exercise

Transaction value
$1,073,772
Shares
+7,200
Change %
+22%
Price
$149.14
Shares after
39,652
Date
12 Aug 2024
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$590,764
Shares
-1,785
Change %
-4.5%
Price
$330.96
Shares after
37,867
Date
12 Aug 2024
Ownership
Direct
Footnotes
F1
CI transaction

Common Stock, $.01 Par Value

Sale

Transaction value
$1,659,088
Shares
-5,034
Change %
-13%
Price
$329.58
Shares after
32,833
Date
12 Aug 2024
Ownership
Direct
Footnotes
F1, F2
CI holding

Common Stock, $.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,195
Date
12 Aug 2024
Ownership
By 401(k)
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-7,200
Change %
-74%
Price
$0.000000
Shares after
2,506
Date
12 Aug 2024
Ownership
Direct
Underlying class
Common Stock, $.01 Par Value
Underlying amount
7,200
Exercise price
$149.14
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2024.

Footnote F2

Represents the weighted average price of the shares sold. The prices actually received ranged from $329.045 to $329.769 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Footnote F4

This option was granted on February 28, 2017. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .